- Poster presentation
- Open access
- Published:
Immunoglobulin therapy of abdominal sepsis in emergency surgery
Critical Care volume 16, Article number: P4 (2012)
Background
The literature data demonstrate that the initial stage of abdominal sepsis (AS) is characterized with typical immune shifts as white blood cell (WBC) activation, decrease of T-lymphocyte and B-lymphocyte function followed by dysimmunoglobulinemia. As AS progresses immunity deficiency acquires severe combined character. Impact of immunity deficiency on a course is not described.
Methods
We investigated 33 patients (male:female = 25:8) with abdominal sepsis (total peritonitis following appendicitis, perforated duodenal ulcer, pancreonecrosis). Anti-endotoxin (AE) antibodies (anti-LPS-IgA, anti-LPS-IgM, anti-LPS-IgG) were determined by original modification of hard-phase immunoenzyme analysis. Escherichia coli K30 LPS was used as antigen for AE antibody detection. All data were compared with healthy donors (99 patients). As a method of immunity correction we selected Sandoglobulin (Novartis, Switzerland), introduced as 3 ml once intravenously.
Results
According to results of immunity parameter investigation on the day of admission we shared all patients into two groups: with high initial immunity (n = 6, no evidence from normal parameters) and low initial immunity (n = 27, evident decrease of AE immunity parameters). All patients needed comprehensive medication support. The patients with high immunity did not need any immunotherapy. But the patients with low initial immunity required immune therapy to avoid severe course of peritonitis and unfavorable outcomes. Single introduction of Sandoglobulin on the fifth day after surgery was accompanied with increase of immunity indices (Table 1). Simultaneously with an increase of anti-LPS-immunoglobulin titer one noticed sharp positive clinical changes (improvement of patients' self-feeling, body temperature decrease, decrease/normalization of WBC number, neutrophil shift). We have the following data about routine laboratory parameters in abdominal sepsis patients with Sandoglobulin introduction: WBC, ×109/l, 16.5 ± 0.9 before introducing and 9.8 ± 1.2 in 2 days after introducing; stab neutrophils, %, 18.3 ± 1.6 and 10.8 ± 1.4 appropriately; juvenile neutrophils, %, 4.1 ± 0.8 and 0.3 ± 0.1 appropriately (all changes are evidently proved, P < 0.001). Successful surgical treatment and immunotherapy of abdominal sepsis are accompanied by activation of AE immunity, all-class anti-LPS-immunoglobulin concentration growth that blocks mechanisms of further inflammation progress and result in rapid patients' recovery.
Conclusion
Peritonitis patients with initial low immunity need passive nonspecific immunotherapy that stimulates organism protective functions and promotes rapid recovery.
Author information
Authors and Affiliations
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Butyrsky, O., Starosek, V. Immunoglobulin therapy of abdominal sepsis in emergency surgery. Crit Care 16 (Suppl 3), P4 (2012). https://doi.org/10.1186/cc11691
Published:
DOI: https://doi.org/10.1186/cc11691